The first year of the program is devoted to an intensive exposure to clinical neuro-oncology and consists of hands-on clinical rotations in both ambulatory and hospital settings at MGH and DFCI/BWH. The training is comprehensive with high patient volumes in primary brain tumors (including gliomas), central nervous system (CNS) lymphoma, CNS metastases, and neurologic complications of cancer and cancer therapy. In one year, our institutions total more than 40,000 outpatient visits, more than 2600 new outpatient visits, and more than 7000 inpatient visits. Both DFCI/BWH and MGH have a large referral basis from New England and beyond for clinical trials.
Management of patients with neuro-oncologic disorders requires multidisciplinary care. Therefore, trainees will also interact extensively with trainees and staff in other outstanding MGH/BWH/DFCI programs including medical oncology, hematology, palliative care, neurology, neurosurgery, radiation oncology, neuroradiology, and neuropathology.